# Timberland Bancorp Inc: overview TSBK · Nasdaq · CIK 1046050 · [Financials](/sectors/financials.md) · fiscal year ends Sep 30 Pages: [Overview](/companies/tsbk.md) · [Financials](/companies/tsbk/financials.md) · [Filings](/companies/tsbk/filings.md) · [Insiders](/companies/tsbk/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.79](/filings/0000939057-25-000319.md) | [0.86](/filings/0000939057-26-000037.md) | [0.85](/filings/0000939057-26-000100.md) | [0.90](/filings/0000939057-26-000156.md) | [1.07](/filings/0000939057-25-000319.md) | [1.04](/filings/0000939057-26-000037.md) | [0.90](/filings/0000939057-26-000100.md) | [0.98](/filings/0000939057-26-000156.md) | | Free cash flow | $m | [6.3 d](/filings/0000939057-25-000319.md) | [(3.6)](/filings/0000939057-26-000037.md) | [12.2 d](/filings/0000939057-26-000100.md) | [10.3 d](/filings/0000939057-26-000156.md) | [9.5 d](/filings/0000939057-25-000319.md) | [5.6](/filings/0000939057-26-000037.md) | [6.2 d](/filings/0000939057-26-000100.md) | [7.8 d](/filings/0000939057-26-000156.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-09-30) | FY2022 (2022-09-30) | FY2023 (2023-09-30) | FY2024 (2024-09-30) | FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [3.27](/filings/0000939057-23-000357.md) | [2.82](/filings/0000939057-24-000331.md) | [3.29](/filings/0000939057-25-000319.md) | [3.01](/filings/0000939057-25-000319.md) | [3.67](/filings/0000939057-25-000319.md) | | Free cash flow | $m | [28.7](/filings/0000939057-23-000357.md) | [25.6](/filings/0000939057-24-000331.md) | [29.9](/filings/0000939057-25-000319.md) | [21.7](/filings/0000939057-25-000319.md) | [28.4](/filings/0000939057-25-000319.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/tsbk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $30.9m | 690,183 | | Added +25,261 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $25.0m | 558,575 | | Added +1,505 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $14.1m | 315,684 | | Reduced −11,914 | | [Cutler Capital Management, LLC](/funds/1353098.md) | 2026-06-30 | $12.8m | 285,258 | | Reduced −5,944 | | [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $12.8m | 284,556 | | Reduced −1,834 | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $11.7m | 260,826 | | Reduced −2,108 | | [Siena Capital Partners GP, LLC](/funds/1694886.md) | 2026-06-30 | $10.3m | 230,847 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $9.5m | 212,589 | | Reduced −5,000 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $8.4m | 187,547 | | Added +14,933 | | [Davis Asset Management, L.P.](/funds/1945894.md) | 2026-06-30 | $7.8m | 174,476 | | Unchanged | ## Recent filings [All 724 filings](/companies/tsbk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-07 | 16:28 ET | [10-Q](/filings/0000939057-26-000156.md) | Quarterly report, period 2026-06-30 | 0000939057-26-000156 | | 2026-07-29 | 17:14 ET | [8-K](/filings/0000939057-26-000145.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000939057-26-000145 | | 2026-05-07 | 17:21 ET | [10-Q](/filings/0000939057-26-000100.md) | Quarterly report, period 2026-03-31 | 0000939057-26-000100 | | 2026-04-30 | 16:54 ET | [8-K](/filings/0000939057-26-000094.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000939057-26-000094 | | 2026-02-06 | 17:37 ET | [10-Q](/filings/0000939057-26-000037.md) | Quarterly report, period 2025-12-31 | 0000939057-26-000037 | | 2026-01-29 | 19:19 ET | [8-K](/filings/0000939057-26-000029.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000939057-26-000029 | | 2026-01-27 | 18:49 ET | [8-K](/filings/0000939057-26-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000939057-26-000020 | | 2026-01-07 | 18:40 ET | [8-K](/filings/0000939057-26-000003.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000939057-26-000003 | | 2025-12-17 | 17:59 ET | [DEF 14A](/filings/0000939057-25-000333.md) | Proxy statement, period 2025-12-17 | 0000939057-25-000333 | | 2025-12-11 | 16:15 ET | [8-K](/filings/0000939057-25-000326.md) | 5.02 Departure or appointment of officers or directors | 0000939057-25-000326 | ## Latest annual report [Form 10-K for the fiscal year ended Sep 30, 2025](/filings/0000939057-25-000319.md), filed Dec 9, 2025. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1046050 - Tickers: TSBK - Exchange: Nasdaq - SIC code: 6036 Savings Institutions, Not Federally Chartered - State of incorporation: WA - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.